95 Participants Needed

Caregiver Support Intervention for Caregiver Stress Syndrome

(TACSI Trial)

JE
Overseen ByJoseph E. Gaugler, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The TBI-AD/ADRD Caregiver Support Intervention (TACSI) incorporates psychosocial and psychoeducational approaches with the objective of: a) identifying stressors associated with caregiving for family members who have the dual diagnosis of traumatic brain injury and dementia; and b) supporting caregivers in developing more effective coping and communication strategies as well as enhanced caregiving self-efficacy.

Do I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are on psychotropic medications like antidepressants, anxiolytics, or anti-psychotics, you must have been on a stable dosage for the past three months to participate.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are on psychotropic medications (like antidepressants or anti-anxiety drugs), you must have been on a stable dose for the past three months to participate.

What data supports the idea that Caregiver Support Intervention for Caregiver Stress Syndrome is an effective treatment?

The available research shows that caregivers of individuals with traumatic brain injury (TBI) and Alzheimer's disease and related dementias (ADRD) face significant challenges, including psychological stress and social isolation. The studies highlight the need for interventions like the Caregiver Support Intervention to address these issues. While specific data on the effectiveness of this intervention is not provided, the research emphasizes the importance of support for caregivers to improve their well-being and resilience. Compared to other treatments, such as the D'Zurilla and Nezu social problem-solving model, which is noted as beneficial, the Caregiver Support Intervention is suggested to be a necessary approach to help caregivers manage stress and improve their quality of life.12345

What data supports the effectiveness of the treatment TBI-AD/ADRD Caregiver Support Intervention (TACSI) for caregiver stress syndrome?

Research shows that caregivers of people with traumatic brain injury (TBI) and Alzheimer's disease face high stress and health issues. Interventions like TACSI, which provide support and education, can help reduce caregiver stress and improve their well-being.12345

What safety data exists for the Caregiver Support Intervention for Caregiver Stress Syndrome?

The provided research does not directly address safety data for the Caregiver Support Intervention for Caregiver Stress Syndrome or its variants like TACSI. The studies focus on the challenges and needs of caregivers for individuals with TBI and ADRD, the effectiveness of remote interventions, and the impact of caregiving. However, they do not provide specific safety data for the intervention itself.13678

Is the treatment TACSI a promising treatment for caregiver stress syndrome?

Yes, TACSI is a promising treatment because it focuses on supporting caregivers of people with traumatic brain injury and Alzheimer's disease. It aims to reduce stress, improve psychological well-being, and provide necessary support and education to caregivers, which are crucial for their health and the care they provide.13568

How is the TACSI treatment different from other treatments for caregiver stress syndrome?

The TACSI treatment is unique because it focuses on providing comprehensive support for caregivers of individuals with traumatic brain injury (TBI) and Alzheimer's disease-related dementias (ADRD), addressing both cognitive and behavioral symptom management and care coordination. Unlike other treatments, it emphasizes interdisciplinary care and support for caregivers, aiming to improve outcomes for both the patients and their caregivers.13568

Eligibility Criteria

This trial is for caregivers over 21 years old in the U.S. who primarily assist a family member with both traumatic brain injury and dementia, are English-speaking, willing to participate, and not receiving similar psychosocial support elsewhere. Caregivers must be stable on any psychotropic medications for three months.

Inclusion Criteria

I am willing to take part in the TACSI evaluation.
The caregiver resides in the US.
I have been diagnosed with both traumatic brain injury and Alzheimer's or related dementia.
See 3 more

Exclusion Criteria

I am a caregiver with a new or worsening mental health issue and not on stable medication.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive the TBI-AD/ADRD Caregiver Support Intervention (TACSI) incorporating psychosocial and psychoeducational approaches

3 months

Follow-up

Participants are monitored for changes in caregiver primary subjective stress

3 months

Extended Follow-up

Participants are further monitored for changes in caregiver primary subjective stress

6 months

Treatment Details

Interventions

  • TBI-AD/ADRD Caregiver Support Intervention (TACSI)
Trial Overview The TACSI program is being tested to help caregivers of individuals with traumatic brain injury and dementia. It aims to identify caregiving stressors and teach effective coping, communication skills, and improve confidence in caregiving abilities.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: TACSIExperimental Treatment1 Intervention
Group II: Usual care control groupActive Control1 Intervention
The usual care control group would have continued receipt of standard services at either the Mayo Clinic or the MVAHCS. In addition, staff will offer participants the opportunity to request supportive/educational resources as needed after randomization.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Minnesota

Lead Sponsor

Trials
1,459
Recruited
1,623,000+

Minneapolis Veterans Affairs Medical Center

Collaborator

Trials
77
Recruited
355,000+

Mayo Clinic

Collaborator

Trials
3,427
Recruited
3,221,000+

United States Department of Defense

Collaborator

Trials
940
Recruited
339,000+

Findings from Research

Interventions specifically targeting family caregivers of adults with traumatic brain injury (TBI) are more effective in reducing caregiver burnout and improving well-being than those aimed at both caregivers and survivors or just the survivors themselves.
The review included 14 studies, primarily randomized clinical trials, but highlighted limitations such as small sample sizes and high risk of bias, suggesting that future research should focus on larger, more rigorously designed studies to better assess the effectiveness of these interventions.
Systematic Review of Caregiver and Dyad Interventions After Adult Traumatic Brain Injury.Kreitzer, N., Kurowski, BG., Bakas, T.[2022]
Caregivers of patients with moderate-to-severe traumatic brain injury (TBI) showed significant improvements in meeting their emotional support needs and knowledge about brain injury after a 5-session intervention, compared to a control group.
However, the benefits of the intervention did not last at the 3-month follow-up, suggesting that caregivers may need ongoing support to maintain these improvements.
A Randomized Controlled Pilot Study of a Manualized Intervention for Caregivers of Patients With Traumatic Brain Injury in Inpatient Rehabilitation.Niemeier, JP., Kreutzer, JS., Marwitz, JH., et al.[2020]
The ABC ANSWERS study is a randomized controlled trial involving 200 dyads of veterans with Alzheimer's disease or traumatic brain injury and their caregivers, aiming to improve caregiver quality of life and reduce caregiver burden over 12 months.
The intervention is based on evidence-based programs and is expected to enhance caregiver well-being by addressing psychological symptoms like depression and anxiety, compared to standard primary care.
Supporting caregivers of veterans with Alzheimer's disease and traumatic brain injury: study protocol for a randomized controlled trial.Carnahan, JL., Judge, KS., Daggy, JK., et al.[2021]

References

Systematic Review of Caregiver and Dyad Interventions After Adult Traumatic Brain Injury. [2022]
A Randomized Controlled Pilot Study of a Manualized Intervention for Caregivers of Patients With Traumatic Brain Injury in Inpatient Rehabilitation. [2020]
Supporting caregivers of veterans with Alzheimer's disease and traumatic brain injury: study protocol for a randomized controlled trial. [2021]
Caregiver resilience following traumatic brain injury: Findings at six months postinjury. [2023]
Caregiver's Burden of the Patients With Traumatic Brain Injury. [2020]
Effectiveness of remote interventions in improving caregiver stress outcomes for caregivers of people with traumatic brain injury. [2021]
Caregivers' perspectives of the challenges faced with survivors of traumatic brain injury: A scoping review. [2021]
Traumatic brain injury: caregivers' problems and needs. [2012]